Trial intelligence / Profile preview

Comparison of Two Treatment Schemes for P. Vivax Malaria in Southern Mexico

NCT02394197Phase 4Completed

Start
Feb 2008
Primary completion
Sep 2010
Modality
Small Molecules
01

Overview

Phase 4, randomised, open-label trial of chloroquine and primaquine in Plasmodium vivax malaria (2 arms). Primary endpoints: Changes in the presence and density of asexual parasites at 12 months, Changes in the presence and severity of clinical symptoms at 12 months and 1 more. Started Feb 2008; status: completed.

02

Drugs

chloroquineprimaquine
03

Conditions

Plasmodium vivax malaria

Beyond the preview

Go deeper on NCT02394197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02394197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call